Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $2.8 in the prior trading day, ProKidney Corp (NASDAQ: PROK) closed at $2.68, down -4.29%. In other words, the price has decreased by -$4.29 from its previous closing price. On the day, 1.67 million shares were traded. PROK stock price reached its highest trading level at $2.88 during the session, while it also had its lowest trading level at $2.635.
Ratios:
Our goal is to gain a better understanding of PROK by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.32 and its Current Ratio is at 10.32.
On September 10, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $6.Guggenheim initiated its Buy rating on September 10, 2024, with a $6 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 12 ’25 when Brian Pereira bought 675,234 shares for $2.70 per share.
Brian Pereira bought 81,928 shares of PROK for $221,205 on Nov 12 ’25. On Jul 08 ’25, another insider, Weber Darin J., who serves as the Chief Regulatory Officer of the company, sold 103,480 shares for $3.02 each. As a result, the insider received 312,510 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PROK now has a Market Capitalization of 806236096 and an Enterprise Value of 1438210816. For the stock, the TTM Price-to-Sale (P/S) ratio is 1089.51. Its current Enterprise Value per Revenue stands at 1933.079 whereas that against EBITDA is -9.013.
Stock Price History:
The Beta on a monthly basis for PROK is 1.81, which has changed by 0.3023256 over the last 52 weeks, in comparison to a change of 0.15085125 over the same period for the S&P500. Over the past 52 weeks, PROK has reached a high of $7.13, while it has fallen to a 52-week low of $0.46. The 50-Day Moving Average of the stock is -4.63%, while the 200-Day Moving Average is calculated to be 46.52%.
Shares Statistics:
The stock has traded on average 2.05M shares per day over the past 3-months and 1652600 shares per day over the last 10 days, according to various share statistics. A total of 135.98M shares are outstanding, with a floating share count of 102.53M. Insiders hold about 27.57% of the company’s shares, while institutions hold 28.69% stake in the company. Shares short for PROK as of 1761868800 were 12294628 with a Short Ratio of 5.98, compared to 1759190400 on 10707361. Therefore, it implies a Short% of Shares Outstanding of 12294628 and a Short% of Float of 12.629999999999999.
Earnings Estimates
The stock of ProKidney Corp (PROK) is currently drawing attention from 2.0 analysts actively involved in the ongoing evaluation and rating process.
Analysts are recommending an EPS of between -$0.41 and -$0.49 for the fiscal current year, implying an average EPS of -$0.45. EPS for the following year is -$0.52, with 5.0 analysts recommending between -$0.38 and -$0.75.
Revenue Estimates
4 analysts predict -$32.5k in revenue for. The current quarter. It ranges from a high estimate of $100k to a low estimate of -$230k. As of. The current estimate, ProKidney Corp’s year-ago sales were $76k
